A new machine-learning approach for prostate-specific membrane antigen (PSMA) treatment of metastatic castration-resistant prostate cancer (mCRPC) could estimate radiation dose to tumors and healthy ...
DELRAY BEACH, Fla., April 2, 2026 /PRNewswire/ -- PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects ...
A groundbreaking new study suggests that prostate cancer treatment may soon become faster, simpler, and less disruptive for thousands of men across the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results